Introduction {#s1}
============

In the United States, 200,000 children a year receive general anesthesia during the first year of life ([@bib48]). Anesthetics have profound effects on all physiological systems. As a consequence, since the mid-1980s, anesthesia caregivers have been required to monitor blood pressure, heart rate, body temperature, and oxygen saturation along with anesthetic gas and oxygen delivery for all patients receiving general anesthesia. The states of general anesthesia and sedation are produced by the anesthetics acting in the brain and spinal cord ([@bib9], [@bib10]; [@bib14]). However, brain monitoring using electroencephalogram (EEG)-derived indices is used to only a limited extent in adults, rarely in children, and essentially not at all in infants. These EEG-derived indices, which been developed in adults can give inaccurate indications of anesthetic states in infants and younger children ([@bib20]; [@bib19]). The lack of principled strategies for monitoring the brains of infants and children receiving anesthesia care is especially troubling in view of growing concern about anesthetic toxicity to the developing brain ([@bib42]; [@bib29]; [@bib38]).

A plausible inference to be drawn from the few available EEG studies of children under general anesthesia is that the inaccuracy of EEG-derived indices in pediatric practice is likely due to differences between children and adults in their brain responses to the anesthetics. A consensus has not been achieved on what these differences are because the available pediatric investigations have studied a limited set of anesthetics and frequently used EEG montages with few electrodes; different analysis methods have been used in different studies; multi-electrode recordings available in children have not been analyzed in function of age; and dose-titration experiments commonly conducted in adults cannot for ethical reasons be conducted in children ([@bib21]; [@bib40]; [@bib25]; [@bib43]; [@bib50]).

For adults, characterizing the anesthetic response of the brain under general anesthesia and sedation is an active research field in which EEG, intracranial recordings, functional magnetic resonance imaging, and positron emission tomography are being used to study spatio-temporal changes in brain activity for different anesthetics and for different doses of the same anesthetic ([@bib24]; [@bib6]; [@bib7]; [@bib44]; [@bib18]; [@bib41]; [@bib45]; [@bib5]; [@bib37]; [@bib12]; [@bib36]; [@bib39]; [@bib46]; [@bib47]; [@bib1]; [@bib53]). For example, a significant EEG pattern observed in adults under propofol general anesthesia and anesthesia maintained by an ether-derived anesthetic is incoherent slow oscillations across the entire head and strongly coherent alpha oscillations across only the front of the head ([@bib47]). Modeling studies suggest that the alpha oscillations are thalamo-cortical in origin ([@bib52]). In addition, it is now appreciated that different anesthetics have different EEG signatures that are readily visible in the unprocessed EEG and its spectrogram ([@bib47]; [@bib2], [@bib3]). These EEG signatures can be related to the altered arousal states the anesthetics produce and to the mechanisms through which the drugs are believed to act at specific receptors in specific brain circuits.

These neurophysiological studies in adults have led to the idea of using the unprocessed EEG and its spectrogram as an alternative to using EEG-derived indices to monitor the brain states of adults receiving general anesthesia or sedation ([@bib11]).

Use of the unprocessed EEG and its spectrogram to develop a neurophysiological-based paradigm tailored to pediatric practices for monitoring anesthetic state requires studying in children the spatio-temporal dynamics of brain responses to anesthetics. To begin to address this key knowledge gap, we used multi-electrode EEG recordings to study the spatial and temporal dynamics of brain activity in infants 0--6 months of age when awake, and during maintenance of and emergence from sevoflurane general anesthesia administered for routine surgical care.

Results {#s2}
=======

Continuous multichannel EEG recordings were collected during the awake state, Maintenance Of a Surgical State of Anesthesia (MOSSA), and emergence from sevoflurane general anesthesia in 36 infants aged 0--6 months postnatal age ([Figure 1](#fig1){ref-type="fig"}). Infant demographics and clinical characteristics are given in [Table 1](#tbl1){ref-type="table"}. Details concerning study procedures and enrollment are given in the 'Materials and methods' and [Figure 2](#fig2){ref-type="fig"}.10.7554/eLife.06513.003Figure 1.Experiment design.(**A**) Experiment timeline: schematic time-course of end-tidal sevoflurane concentration during the awake phase, induction, MOSSA (Maintenance of Surgical State of Anesthesia), and emergence phases of general anesthesia. Electroencephalogram (EEG) data from individual recording electrodes were analyzed post hoc for the awake brain state prior to anesthesia (shown in green), and two phases of general anesthesia (i) MOSSA (shown in red), and (ii) emergence from general anesthesia (shown in blue). (**B**) EEG montage used (modified international 10/20 electrode placement system).**DOI:** [http://dx.doi.org/10.7554/eLife.06513.003](10.7554/eLife.06513.003)10.7554/eLife.06513.004Table 1.Infant demographics and clinical characteristics**DOI:** [http://dx.doi.org/10.7554/eLife.06513.004](10.7554/eLife.06513.004)All infants (N = 30)0--3 M (n = 11)4--6 M (n = 19)Difference between medians in each age groupp-valueDemographicsPMA at birth (weeks)[\*](#tblfn1){ref-type="table-fn"}39.0 (CI: 37.6--39.0)37.0 (CI: 34.0--39.0)39.0 (CI: 39.0--39.0)2.0**0.02**PNA at study (months)[\*](#tblfn1){ref-type="table-fn"}5.5 (CI: 3.6--6.1)2.8 (CI: 0.5--3.5)6.1 (CI: 5.5--6.1)3.3--Weight at study (kg)[\*](#tblfn1){ref-type="table-fn"}6.8 (CI: 6.1--7.6)5.0 (CI: 4.1--6.3)7.6 (CI: 6.7--8.2)----Male \[%, (n)\][†](#tblfn2){ref-type="table-fn"}83.3 (25)72.7 (8)89.5 (17)--0.24Procedure typeGeneral surgery \[%, (n)\]53.3 (16)90.9 (10)31.6 (6)----Urological \[%, (n)\]46.7 (14)9.1 (1)68.4 (13)----General anesthetic managementNitrous oxide for induction \[%, (n)\][\*](#tblfn1){ref-type="table-fn"}76.7 (23)54.5 (6)94.7 (17)--0.07Propofol \[%, (n)\][\*](#tblfn1){ref-type="table-fn"}36.7 (11)27.3 (3)42.1 (8)--0.47Propofol cumulative dose (mg/kg)[\*](#tblfn1){ref-type="table-fn"}15 (CI: 10--20)10 (CI: 10-10)15 (CI: 10--20)50.08Median duration of anesthesia (min)[\*](#tblfn1){ref-type="table-fn"}108.5 (CI: 87--145)118.0 (CI: 81--268)94.0 (CI: 76--160)−24.00.18MOSSA epoch detailEnd-tidal sevoflurane (%)[\*](#tblfn1){ref-type="table-fn"}2.6 (CI: 2.2--2.7)2.0 (CI: 0.8--2.6)2.6 (CI: 2.4--3.1)0.7**0.002**[^3][^4][^5][^6][^7]10.7554/eLife.06513.005Figure 2.Study profile.Parents of 51 infants were approached and 36 consented. Five EEG recordings were excluded from the final analysis because of technical failures (n = 4) or a clinical event (n = 1; local anesthetic toxicity prior to surgical incision). For MOSSA analysis, data are presented from 30 EEG recordings (0--3 months, n = 11; 4--6 months, n = 19); for awake analysis, 19 infants were included (0--3 months, n = 7; 4--6 months, n = 12); and for emergence from general anesthesia analysis, 24 infants were included (0--3 months, n = 8; 4--6 months, n = 16).**DOI:** [http://dx.doi.org/10.7554/eLife.06513.005](10.7554/eLife.06513.005)

EEG features during MOSSA {#s2-1}
-------------------------

### Slow and delta oscillations are present from 0 to 6 months of age; theta and alpha oscillations emerge around 4 months of age {#s2-1-1}

Frontal power spectra analysis in individual infants at F7 showed that slow (0.1--1 Hz) and delta power (1--4 Hz) were present at all ages ([Figure 3](#fig3){ref-type="fig"}). Power in the 4--30 Hz frequency range was minimal in infants at 1, 2, and 3 months of age ([Figure 3A,B](#fig3){ref-type="fig"}). Power in the theta (4--8 Hz) and alpha (8--12 Hz) frequency ranges emerged at 4, 5, and 6 months of age ([Figure 3C,D](#fig3){ref-type="fig"}). Based on these key features of the individual power spectra, infants were divided according to postnatal age into two groups, 0--3 months (n = 11) and 4--6 months (n = 19) for subsequent analyses.10.7554/eLife.06513.006Figure 3.Frontal spectrograms during MOSSA.Individual infant EEG spectral power for frequencies from 0 to 30 Hz (left hand axis) during a 5-min period of MOSSA. Frontal spectrograms for infants at 0--3 months of age are shown for (**A**) individual infants and (**B**) group-median average. Frontal spectrograms for infants at 4--6 months of age are shown for (**C**) individual infants and (**D**) group-median average. F7 used with nearest neighbor Laplacian referencing.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.006](10.7554/eLife.06513.006)

Frontal group-median spectrograms computed at F7 in infants 0--3 months and 4--6 months of age show that power in the slow and delta ranges was dominant over that in other frequencies in both age groups ([Figure 3B,D](#fig3){ref-type="fig"}). Oscillations in the theta and alpha ranges were more prominent in infants aged 4--6 months during MOSSA.

Power across all frequencies was lower in infants at 0--3 months compared to infants at 4--6 months of age during MOSSA ([Figure 4A](#fig4){ref-type="fig"}). Infants 0--3 months of age showed negligible frontal alpha power (F7) with a peak of −6.52 dB at 8 Hz. Infants 4--6 months of age showed increased alpha power with a peak of 6.68 dB at 9 Hz. Group comparisons showed that power was significantly lower (95% Confidence Interval (CI), bootstrap analysis) across all of the frequencies from 0 to 30 Hz in infants 0--3 months of age, when compared with infants 4--6 months of age during MOSSA ([Figure 4B--E](#fig4){ref-type="fig"}).10.7554/eLife.06513.007Figure 4.Frontal EEG power is greater in infants 4--6 months of age across all frequencies during MOSSA.(**A**) Frontal group-median power spectra (solid line, median; shaded area, 25th--75th percentile) across the 0--30 Hz-frequency band showing increased power in infants 4--6 months of age across all frequencies. (**B-E**) Differences in frontal group-median power spectra presented with 95% CI from bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) comparing infants at 0--3 month to 4--6 months of age. (**B**) Power difference in slow and delta frequency range, 0--4 Hz, (**C**) theta, 4--8 Hz, (**D**) alpha, 8--12 Hz, and (**E**) beta, 12--30 Hz. F7 electrode presented using nearest neighbor Laplacian referencing.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.007](10.7554/eLife.06513.007)10.7554/eLife.06513.008Figure 4---figure supplement 1.Frontal EEG spectral properties in infants anesthetized under a uniform end-tidal sevoflurance concentration (1.8%).Group-averaged frontal power spectrograms in infants (**A**) 0--3 months of age, and (**B**) 4--6 months of age (**C**) Frontal group-median power spectra (solid line, median; shaded area, 25th--75th percentile) across 0--30 Hz frequencies. (**D**--**G**) Differences in group-averaged frontal power spectra presented with 95% CI from bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) comparing infants at 0--3 months to infants at 4--6 months of age. F7 electrode presented using nearest neighbour Laplacian referencing. etSEVO: end-tidal sevoflurance concentration. Epoch size of 30 s is used.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.008](10.7554/eLife.06513.008)

End-tidal sevoflurane requirements during MOSSA were significantly lower in infants 0--3 months compared to infants 4--6 months of age ([Table 1](#tbl1){ref-type="table"}). Therefore, we performed a secondary analysis to control for potential dose effects by comparing EEG spectra during MOSSA at identical end-tidal sevoflurane concentrations of 1.8% across infants. We chose 1.8% end-tidal sevoflurane because all the infants received this concentration for at least 30 s during surgery and did not exhibit body movement or reflex activity at this plane of anesthesia suggesting a behavioral state comparable to MOSSA. At 1.8% end-tidal sevoflurane, frontal group-median spectrograms at F7 show that slow and delta power was dominant over other frequencies in both age groups ([Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}). Higher frequency oscillations in the theta and alpha range were more prominent in infants 4--6 months of age ([Figure 4---figure supplement 1C--G](#fig4s1){ref-type="fig"}). The patterns of EEG activity observed during MOSSA were also seen during lighter planes of MOSSA at 1.8% end-tidal sevoflurane suggesting that the observed differences between the two groups are not likely due to a dose effect.

### Frontal alpha predominance is low at 0--6 months of age {#s2-1-2}

Group-median spectrograms were computed for each recording electrode location in the EEG montage ([Figure 5](#fig5){ref-type="fig"}). Infants 0--3 months of age showed slow and delta power at each electrode location and an absence of appreciable power at any frequency 5 Hz and higher. The power difference between the slow--delta range and the \>5 Hz range was 30--35 dB. Infants 4--6 months of age group showed appreciable power in the slow, delta, theta, and alpha bands in the parietal, temporal, and non-central electrode locations; all the midline electrode locations showed less power in the frequencies 5 Hz and higher.10.7554/eLife.06513.009Figure 5.Spatial distribution of spectral power during MOSSA.Group-median spectrograms at each recording electrode location across the scalp in infants at (**A**) 0--3 months (n = 11) and (**B**) 4--6 months (n = 19).**DOI:** [http://dx.doi.org/10.7554/eLife.06513.009](10.7554/eLife.06513.009)

Topographic maps of power were computed for slow, delta, theta, alpha, and beta frequency bands ([Figure 6](#fig6){ref-type="fig"}). For both age groups, spectral power along the midline (specifically frontal and central-parietal locations) was lower across all frequencies ([Figure 6A,B](#fig6){ref-type="fig"}). Slow and delta oscillations were broadly distributed across the entire scalp, with slightly lower power located over the frontal, centro--parietal, and occipital midline compared to the temporal regions in all infants. Theta activity followed a similar distribution pattern in all infants, although infants 0--3 months of age had minimal power in this range (\<0 dB) ([Figure 6A](#fig6){ref-type="fig"}). During MOSSA, alpha oscillations, compared to lower frequency bands, were distributed more laterally across the frontal, central, and parietal regions in infants 4--6 months of age ([Figure 6B](#fig6){ref-type="fig"}). Alpha power was slightly lower over the central--parietal and occipital midline, possibly reflecting changes in skull conductivity over the locations of fontanels, rather than an artifact of referencing technique.10.7554/eLife.06513.010Figure 6.Topographic EEG maps of spectral power for distinct frequency bands during MOSSA.Topographic EEG maps detailing group-averaged power for each EEG frequency band in infants aged (**A**) 0--3 months (n = 11) and (**B**) 4--6 months (n = 19). Slow-wave activity is distributed across the scalp in both postnatal age groups, while alpha activity is present to a greater degree in infants 4--6 months postnatal age. Legend for **A** and **B** is shown by the color bar.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.010](10.7554/eLife.06513.010)

We evaluated the potential frontal predominance of alpha power by assessing power spectra differences between frontal (FPz) and occipital (Oz) electrodes for infants 0--3 months of age ([Figure 7A,C--F](#fig7){ref-type="fig"}) and for infants 4--6 months of age ([Figure 7B,G--J](#fig7){ref-type="fig"}). During MOSSA, there were no significant frontal-occipital power differences at any frequency in infants at 0--3 months (95% CI, paired bootstrap analysis) ([Figure 7C--F](#fig7){ref-type="fig"}). In contrast, a small but significant increase in frontal alpha power compared to occipital power (95% CI, paired bootstrap analysis) was present during MOSSA in infants 4--6 months of age ([Figure 7G--J](#fig7){ref-type="fig"}). These data suggest, that unlike in adults, infants 0--3 months of age do not show frontal predominance of alpha power during MOSSA, and that it may begin to emerge at around 4 months postnatal age ([@bib46]; [@bib47]).10.7554/eLife.06513.011Figure 7.Frontal predominance of alpha power is low during MOSSA in infants 0--6 months of age.Frontal group-median power spectra (solid line, median; shaded area, 25th--75th percentile) showing similar EEG power across all frequencies in frontal and occipital channels in infants aged (**A**) 0--3 months (n = 11) and (**B**) 4--6 months (n = 19). Differences in frontal group-median power spectra presented with 95% CI from bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) between frontal and occipital channels during MOSSA in infants aged (**C**--**F**) 0--3 months and (**G**--**J**) 4--6 months. A small but significant increase in frontal alpha power compared to occipital alpha power begins to emerge at 4--6 months of age. FPz and Oz electrodes presented using nearest neighbor Laplacian referencing.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.011](10.7554/eLife.06513.011)

### Frontal alpha coherence is absent at 0--6 months of age {#s2-1-3}

We analyzed the level of local coordinated activity in the frontal regions of the scalp during MOSSA by computing the coherogram (time-varying coherence) and coherence between the left (F7) and right (F8) frontal electrodes (see 'Materials and methods') ([Figure 8A--D](#fig8){ref-type="fig"}). The frontal coherograms showed high coherence (∼0.6) in the slow and delta frequency ranges for all infants during MOSSA ([Figure 8E,F](#fig8){ref-type="fig"}). In infants 0--3 months of age, the peak coherence was 0.61 and occurred at 1.0 Hz ([Figure 8G](#fig8){ref-type="fig"}). In infants aged 4--6 months, peak coherence was also 0.61, and occurred at 1.0 Hz ([Figure 8G](#fig8){ref-type="fig"}). These results suggest that infants across all postnatal ages have coordinated local frontal slow and delta oscillations during MOSSA.10.7554/eLife.06513.012Figure 8.Frontal alpha coherence is absent during MOSSA in infants from 0 to 6 months postnatal age.Group-averaged frontal spectrograms in infants aged 0--3 months at (**A**) Left---F7, and (**B**) Right---F8, and infants aged 4--6 months (**C**) F7, and (**D**) F8. Relative group-averaged frontal coherogram (F7--F8) for infants aged (**E**) 0--3 months and (**F**) 4--6 months age. (**G**) Frontal group-median coherence (solid line, median) showed similar coherence across 0.1--30 Hz frequency bands at all postnatal ages.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.012](10.7554/eLife.06513.012)

Although infants 4--6 months of age showed strong power in the theta and alpha bands ([Figure 8C,D](#fig8){ref-type="fig"}), oscillations in these bands were not coherent ([Figure 8G](#fig8){ref-type="fig"}). This contrasts with adults who show a strong frontal coherence in the alpha band during sevoflurane general anesthesia ([@bib3]). There were no discernable differences between age groups in the level of coherence between 0.1 and 30 Hz (95% CI, bootstrap analysis).

### Global coherence is weak across all frequencies at 0--6 months of age {#s2-1-4}

Global coherence analysis characterizes coordinated activity across multiple channels of EEG as a function of frequency. Global coherence is the fraction of variance at a given frequency across all EEG channels that is explained by the first eigenvector of the cross-spectral matrix. Topographic maps of coherence were computed for slow, delta, theta, alpha, and beta frequency bands in infants 0--3 months of age ([Figure 9A](#fig9){ref-type="fig"}) and infants 4--6 months of age ([Figure 9B](#fig9){ref-type="fig"}) during MOSSA. Despite slow and delta oscillations in the spectrograms at all ages, and theta and alpha oscillations in the spectrograms of infants 4--6 months of age, global coherence was weak (\<0.2) in all frequency bands for all infants ([Figure 9C](#fig9){ref-type="fig"}). This finding contrasts with the pattern of highly coordinated, coherent frontal alpha activity observed in adults during propofol general anesthesia ([@bib18]; [@bib47]; [@bib3]). The lack of global coherence in the slow and delta frequency ranges is consistent with the lack of slow oscillation coherence observed in adults ([@bib18]; [@bib37]; [@bib47]).10.7554/eLife.06513.013Figure 9.Global coherence is low across all frequencies during MOSSA in infants from 0 to 6 months of age.Topographic EEG maps detailing group-averaged global coherence for each EEG frequency band in infants (**A**) 0--3 months (n = 11) and (**B**) 4--6 months (n = 19) of age. (**C**) Group-median global coherence spectra (solid line, median; shaded area, IQR) show similar low coherence across 0--30 Hz frequency bands at all ages during MOSSA.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.013](10.7554/eLife.06513.013)

EEG features during awake state {#s2-2}
-------------------------------

We evaluated the EEG features during the awake state (prior to anesthesia exposure) in infants whom awake EEG could be recorded. This was 7 infants in the 0--3 month age group and 12 infants in the 4--6 month age group. Body movement and/or eye opening prior to exposure of sevoflurane general anesthesia were used to confirm the presence of the awake state. Frontal group-median spectrograms at F7 showed dominant slow and delta power, with low theta and alpha power in all ages, were the predominant frequencies during the awake state at all ages ([Figure 10---figure supplement 1A--C](#fig10s1){ref-type="fig"}). Power across all frequencies was significantly lower in infants at 0--3 months compared to infants at 4--6 months of age (95% CI, bootstrap analysis; [Figure 10---figure supplement 1D--G](#fig10s1){ref-type="fig"}).

### Comparison of EEG spectral features in the awake (pre-anesthesia) state and MOSSA {#s2-2-1}

#### Theta and alpha oscillations increase in power during MOSSA in infants 4--6 months of age {#s2-2-1-1}

Slow and delta power remained relatively constant in all infants during the awake state and MOSSA ([Figure 10A,B](#fig10){ref-type="fig"}). There were no clear associations between power in any frequency band and the awake state or MOSSA in infants 0--3 months of age ([Figure 10A](#fig10){ref-type="fig"}). Power in the theta (\>5 Hz) and alpha frequency ranges were prominent features during MOSSA in infants 4--6 months of age ([Figure 10B](#fig10){ref-type="fig"}). Infants 0--3 months of age showed no change in theta or alpha activity associated with general anesthesia (95% CI paired bootstrap analysis, [Figure 10D,E](#fig10){ref-type="fig"}). In infants 4--6 months of age, the relationship between theta and alpha power and general anesthesia was significant (95% CI, paired bootstrap analysis; [Figure 10H,I](#fig10){ref-type="fig"}).10.7554/eLife.06513.014Figure 10.Frontal EEG power changes between the awake state and MOSSA.(**A**) Group-averaged frontal power spectra (solid line, median; shaded area, 25th--75th percentile) show similar EEG power during the awake state (prior to anesthesia) and MOSSA in infants aged 0--3 months across all frequencies (n = 7). (**B**) Group-averaged frontal power spectra show increased theta, alpha, and gamma oscillations during MOSSA in infants 4--6 months of age (n = 12). Differences in group-averaged frontal power spectra presented with 95% CI from paired bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) between Awake and MOSSA in infants (**C**--**F**) 0--3 months and (**G**--**J**) 4--6 months of age. F7 electrode presented using nearest neighbor Laplacian referencing. Epoch size of 11 s is used for awake and MOSSA states.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.014](10.7554/eLife.06513.014)10.7554/eLife.06513.015Figure 10---figure supplement 1.Frontal EEG spectral properties in awake infants.Frontal group-median spectrograms in infants (**A**) 0--3 months, and (**B**) 4--6 months of age. (**C**) Frontal group-median power spectra (solid line, median; shaded area, 25th--75th percentile) across 0--30 Hz frequencies. (**D**--**G**) Differences in frontal group-median power spectra presented wtih 95% CI from bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) comparing infants aged 0--3 months to infants 4--6 months of age. F7 electrode presented using nearest neighbor Laplacian referencing. Epoch size of 11 s is used.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.015](10.7554/eLife.06513.015)

EEG features during emergence {#s2-3}
-----------------------------

### Theta and alpha oscillations decrease in power during emergence in infants 4--6 months of age {#s2-3-1}

On emergence, infants started to display gross body movement at a median end-tidal concentration of 0.6% (95% CI, 0.2--1.0%), and 0.4% (95% CI, 0.3--0.6%) at 0--3 month of age and 4--6 months of age, respectively ([Figure 11](#fig11){ref-type="fig"}). No infants exhibited body movement at 1.2% or greater end-tidal sevoflurane concentrations.10.7554/eLife.06513.016Figure 11.End-tidal sevoflurane concentration associated spatial EEG power and body movement during emergence from sevoflurane general anesthesia.(**A**) End-tidal sevoflurane concentration increments from MOSSA to emergence from general anesthesia for infants 0--3 months (n = 8), and (**B**) 4--6 months of age (n = 16), and (**C**) the corresponding percentage of infants who displayed gross body movement MOSSA.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.016](10.7554/eLife.06513.016)

Slow and delta power remained relatively constant in infants of all ages as end-tidal sevoflurane concentration decreased during MOSSA through emergence ([Figure 11](#fig11){ref-type="fig"}). There were no clear associations between power in any frequency band and change in end-tidal sevoflurane concentration in infants 0--3 months of age ([Figure 11A](#fig11){ref-type="fig"}). Theta and alpha power was constant and sizable at end-tidal sevoflurane concentrations greater than 1.2% in infants 4--6 months of age ([Figure 11B](#fig11){ref-type="fig"}). Theta and alpha power began to decrease once end-tidal sevoflurane concentration fell below 1.2%, and gross body movement started to appear, in infants 4--6 months of age. In these older infants, theta and alpha activity decreased to negligible power levels at end-tidal sevoflurane concentrations where more than 50% of infants displayed gross body movement. Topographic mapping of the power spectral content showed that there was no spatial shift in alpha activity at any end-tidal sevoflurane concentration in older infants. This finding contrasts the adult pattern where anesthesia-induced frontal alpha oscillations disappear and are replaced by posterior alpha during recovery of consciousness ([@bib46]; [@bib47]).

### Comparison of EEG spectral features during MOSSA and first body movement {#s2-3-2}

We evaluated frontal power spectra at the frontal channel (F7) at two time periods (1) MOSSA, and (2) immediately after first body movements were recorded ([Figure 12](#fig12){ref-type="fig"}). Infants 0--3 months of age showed no change in power across any frequency with recovery of movement during emergence (95% CI, paired bootstrap analysis; [Figure 12C--F](#fig12){ref-type="fig"}). In infants 4--6 months of age, the relationship between theta and alpha power and recovery of movement was significant (95% CI, paired bootstrap analysis; [Figure 12G--J](#fig12){ref-type="fig"}). We note that two infants included in the 0--3 month age group exhibited low levels of alpha power at MOSSA that decreased during emergence. These infants were 107 and 116 postnatal days, almost 4 months of age, and suggest the underlying circuitry begins to become more refined at this developmental age, starting to reflect similar properties to infants 4--6 months of age.10.7554/eLife.06513.017Figure 12.Frontal EEG power changes between MOSSA and body movement.(**A**) Frontal group-median power spectra (solid line, median; shaded area, 25th--75th percentile) show similar EEG power during MOSSA and after first body movement in infants aged 0--3 months across all frequencies. (**B**) Frontal group-median power spectra show increased theta and alpha oscillations during MOSSA in infants aged 4--6 months. Differences in frontal group-median power spectra presented with 95% CI from bootstrap analysis (pink line, 97.5th percentile; green line, 2.5th percentile) between MOSSA and emergence after first body movement in infants (**C**--**F**) 0--3 months and (**G**--**J**) 4--6 months of age. F7 electrode presented using nearest neighbor Laplacian referencing.**DOI:** [http://dx.doi.org/10.7554/eLife.06513.017](10.7554/eLife.06513.017)

Discussion {#s3}
==========

We used multi-electrode EEG recordings to characterize the spatial and temporal dynamics of brain activity in infants 0--6 months of age during the awake state, and maintenance of and emergence from sevoflurane general anesthesia for routine surgical care. We showed that during maintenance: (1) all infants had slow oscillations across the entire scalp ([Figures 3--6](#fig3 fig4 fig5 fig6){ref-type="fig"}); (2) theta and alpha oscillations were present in addition to the slow oscillations across the entire scalp in all infants 4 months and older ([Figures 3--6](#fig3 fig4 fig5 fig6){ref-type="fig"}); (3) across all frequencies, the frontal power in the EEG was significantly greater in the 4- to 6-month-old infants compared to 0- to 3-month-old infants ([Figure 4](#fig4){ref-type="fig"}); (4) unlike in adults, all 0- to 6-month-old infants showed an absence of frontal alpha coherence as well as an absence of frontal predominance in power ([Figures 5--9](#fig5 fig6 fig7 fig8 fig9){ref-type="fig"}), although a small but significant increase in frontal alpha power compared to occipital alpha power emerged in infants 4--6 months of age ([Figure 6](#fig6){ref-type="fig"}). We also showed that alpha oscillations increase in power when switching from the awake state to MOSSA in infants 4--6 months of age ([Figure 10](#fig10){ref-type="fig"}); and that during emergence, in infants 4--6 months of age power decreased in the alpha and theta bands with decreasing end-tidal sevoflurane concentration ([Figures 11](#fig11){ref-type="fig"}, [12](#fig12){ref-type="fig"}). Because we made video recordings during our studies, we related changes in anesthetic concentration to return of movement as an approximate behavioral marker of emergence from general anesthesia ([Figures 11](#fig11){ref-type="fig"}, [12](#fig12){ref-type="fig"}).

Studies of EEG dynamics of infant brain under general anesthesia {#s3-1}
----------------------------------------------------------------

Age-related differences in EEG properties have been shown in previous studies of infants and children receiving general anesthesia. Davidson and colleagues monitored 8 leads of EEG in 17 infants, 0--6 months of age, who received either sevoflurane or propofol general anesthesia ([@bib21]). These infants were part of a study cohort that ranged in age from 9 days to 12 years. While total spectral power---limited to 2--20 Hz---did not differ between the anesthetized state and emergence, the EEG traces of the infants during emergence showed bursts of electrical activity interspersed with periods of low-amplitude activity. In contrast, the 21 children aged 2--10 years showed a significant increase in SEF90 and a significant decrease in total frontal EEG power during emergence. Lo and colleagues studied emergence by monitoring 128 leads of EEG in children 22 days to 3.6 years who received either sevoflurane or isoflurane anesthesia ([@bib40]). These investigators reported differences between the spatial EEG patterns of the two agents. However, none of the analyses was stratified by age.

Hayashi and colleagues conducted a retrospective study on EEG data collected using a 2-electrode montage in 62 neonates and infants ranging in age from 1 day to 2 years who received sevoflurane general anesthesia ([@bib25]). They analyzed changes in 90% spectral edge frequency (SEF90), burst suppression ratio (BSR), relative beta ratio (RBR), and approximate entropy (ApEn) to assess changes in brain activity during emergence. They found that infants less than 6 months had little to no change in EEG parameters during emergence, whereas the infants 6 months and older showed the greatest changes in the EEG parameters, which were an increase in the SEF90, decrease in the BSR, increase in the RBR, and decrease in ApEn. The infants in the range of 3--5 month old marked the transition between no EEG changes on emergence to highly visible changes on emergence. Sury and colleagues studied 20 infants at 1 week to 10 months of age during emergence from sevoflurane general anesthesia using a 4-lead EEG montage to analyze spectral power between 1 and 28 Hz ([@bib50]). They found that infants 3 months and older had greater power in the 5--20 Hz range during maintenance than infants less than 3 months and that the power in the older infants decreased on emergence.

Our results refine the results in these reports by showing that there are readily discernible differences in the anesthetic responses of infant 0--3 months of age and infants 4--6 months of age. We report for the first time detailed spatio-temporal analyses of infant 33-lead EEGs with Laplacian referencing using spectra (analyzed from 0.1--30 Hz), spectrograms, coherograms, and global coherence computed by multitaper spectral analysis methods. These methods, which are known to have several important optimality properties, have been used successfully to characterize the EEG dynamics of adults receiving general anesthesia and sedation ([@bib18]; [@bib46]; [@bib47]; [@bib2], [@bib3]). Moreover, the spectrograms are particularly important because they are the frequency domain representations of the EEG displayed on commercially available EEG monitors.

Studies of EEG dynamics in adults under general anesthesia {#s3-2}
----------------------------------------------------------

It is now appreciated that in adults at surgical levels of general anesthesia maintained by GABAergic anesthetics (ether-based agents, barbiturates, propofol), the EEG shows slow oscillations and alpha oscillations, in addition to anteriorization, defined as the movement predominantly of the EEG power in the alpha band from the occipital to the frontal area of the head ([@bib24]; [@bib18]; [@bib45]; [@bib46]; [@bib47]; [@bib2], [@bib3]). Studies of propofol have shown that these alpha oscillations are strongly coherent across the front of the head during unconsciousness, whereas the slow oscillations are not coherent anywhere across the head ([@bib37]; [@bib47]). With return of consciousness, the frontal alpha power disappears, and posterior alpha reappears ([@bib47]). Because we did not record EEG in the infants continuously and then administer sevoflurane in a gradual escalating and a gradual deescalating manner, our study could not assess anteriorization. During MOSSA, we see a small, but significant, increase in frontal alpha power when compared to occipital power in infants 4--6 months, which suggests this feature of anesthetic-induced consciousness emerges in early life. Nevertheless, our findings demonstrate that the spatio-temporal dynamics of the anesthetized states of 0- to 3-month-old and 4- to 6-month-old infants differ appreciably from each other and from those of adults.

Mechanisms for alpha, slow, and delta oscillations {#s3-3}
--------------------------------------------------

Recent modeling studies of propofol offer insights into the possible origins of these differences. These studies suggest that the frontal EEG alpha oscillations likely represent oscillatory activity between the cortex and thalamus ([@bib15]). Other modeling work suggests that anteriorization is due to different effects of propofol on thalamic nuclei that project to occipital areas compared to thalamic nuclei that project to areas of the pre-frontal cortex ([@bib52]). Propofol disrupts the normal, depolarized alpha oscillations in posterior-projecting thalamic nuclei whereas it induces, hyperpolarized alpha oscillations in frontal-projecting thalamic nuclei. The differential effect appears to be due primarily to propofol\'s inhibition of subset of posterior-projecting neurons with hyperpolarizing activating I~h~ currents that typically produce alpha oscillations at resting membrane voltages above 60 millivolts ([@bib52]). The slow and delta oscillations during general anesthesia are consistent with anesthetic-induced decreases in major excitatory brainstem inputs to the cortex. GABAergic anesthetic likely produce these effects by acting at the GABAergic synapses arising from inhibitory neurons in the pre-optic area of the hypothalamus that project onto each of the major arousal nuclei in the midbrain and upper pons ([@bib10]). Both the alpha, slow and delta oscillations likely reflect disruption of thalamo-cortical and cortico-cortical processing required to maintain consciousness ([@bib15]; [@bib47]).

The model predictions for the frontal predominance of alpha oscillations await experimental verification. However, the neuroanatomy and neurophysiology underlying the putative mechanism for alpha oscillations suggest that the thalamocortical connections required to produce the alpha oscillations are absent in infants 0--3 months old yet, present in infants 4--6 months old. The putative mechanism for frontal predominance of alpha power suggests that the differential thalamic connectivity required to produce this phenomenon is not present in infants 6 months of age or younger.

Brain development as a source of changes in EEG dynamics with age {#s3-4}
-----------------------------------------------------------------

Developmental changes in the brain are the obvious mechanisms to explain the changes in EEG dynamics that occur with age. Gross brain development occurs in a caudal to rostral direction, with myelination of the medulla, pons, and thalamus starting within the first few postnatal weeks and frontal cortex myelination starting around postnatal months 3--4 ([@bib8]; [@bib33]). In addition, there is significant synaptogenesis, neuronal differentiation, and pruning, along with changes in GABAergic neurotransmission ([@bib28]; [@bib26]; [@bib51]; [@bib22]; [@bib13]; [@bib49]). Distinct regional differences in the rate of synaptogenesis, glucose metabolism, and myelination across the cortex occur between subcortical and cortical regions, and between different regions of the cortex during the first 12 postnatal months in human infants. For example, in the visual cortex, there is a rapid burst of synapse formation between 3 and 4 months, and the maximum density is reached between 8 and 12 months ([@bib27]). Synaptogenesis starts at the same time in the pre-frontal cortex, but the density of synapses increases much more slowly and does not peak until after the first 12 months ([@bib30]). Additionally, Positron Emission Tomography (PET) studies show that between 0 and 3 months postnatal age, glucose uptake is highest in the occipital parietal, and temporal cortices; and by 6--8 months, glucose uptake extends to the frontal cortex appearing with higher cortical function ([@bib16]; [@bib17]; [@bib32]). A key role in brain development is played by the subplate neurons, the first neurons generated in the cerebral cortex, which guide formation of thalamocortical connections ([@bib31]; [@bib35]). The subplate cells form the first functional connections and are a must for relaying early oscillatory activity in the developing brain ([@bib31]). To the extent that the alpha oscillations in the anesthetized brain are postulated to be produced by thalamocortical circuits, the appearance of the alpha oscillations at 4 months of age may suggest that an important developmental milestone has been reached in the processes guided by the subplate neurons.

Study limitations and constraints {#s3-5}
---------------------------------

The conduct of research in children carries with it all the ethical obligations of adult research along with the additional obligation of not exposing children to risks beyond those associated with their routine medical care. As a consequence, observational studies of children receiving general anesthesia or sedation as part of routine diagnostic or therapeutic care are and will continue to be the principal approach to studying the neurophysiology of general anesthesia in children. It is crucial to plan carefully these studies and their subsequent analyses in order to maximize the information learned on this important topic. Anesthetic management was only standardized in our study to the extent that the staff at Boston Children\'s Hospital uses similar practices. The specific anesthetic management in each case was carried out by the attending anesthesiologist. Given the strength of the findings we report, a more systematic protocol would likely provide more evidence for our findings.

Because administration of general anesthesia is a high-risk human study, dose-titration protocols that are common in adults for studying controlled induction and emergence cannot be conducted in children. Therefore, we conducted our dose--response analysis ([Figure 11](#fig11){ref-type="fig"}), like those reported in previous studies, by observing changes in end-tidal sevoflurane concentration during emergence instead of by recording EEG while systematically changing the anesthetic dose during induction. In place of formal behavioral assessments of consciousness, which would not be feasible in children, we used movement recorded on video as an approximate behavioral marker of emergence from general anesthesia. The advantage of using body movement as a measure of emergence is that it is well-defined in children, and video recordings of body movement can be time-locked to the EEG recording for quantitative analysis. Relating onset of emergence to changes in respiration and heart rate, as well as blood pressure, also reflect effects of anesthesia but in a more complex manner being dependent on drug administration and clinical state of the patient. Similar to what we observed in adults, we found concentration- and behavior-dependent reductions in alpha and theta power during emergence in 4- to 6-month-old infants. Unlike in adults, we did not observe any relationship between slow/delta power and anesthetic concentration or behavior. The differences in slow/delta oscillation dynamics between these infants and adults may be attributable to a number of factors, including mechanistic differences the two groups, low signal-to-noise in the slow/delta band due to patient movement, and the possibility that the infants remained sedated or unconscious despite recovering movement immediately following surgery. Our comparisons between the awake state, MOSSA and emergence indicate that state-specific EEG spectral properties begin to emerge at 4--6 months of age. They demonstrate the challenges faced when using EEG measures to evaluate anesthetic depth in younger infants (0--3 months). Our findings can be strengthened by studying sevoflurane general anesthesia in children across the entire pediatric age spectrum, and by conducting similar studies of other the anesthetics, for example, propofol, dexmedetomidine, and isoflurane, commonly used in children.

Clinical implications and future directions {#s3-6}
-------------------------------------------

In summary, we have shown that infants 0--6 months of age have markedly different EEG patterns from each other and from adults under general anesthesia. These differences are likely due to differences in structural and functional aspects of cortico-cortical and thalamocortical connectivity, and help explain why EEG-based indices provide inaccurate measures of anesthetic states in children, especially during the first three months of life. We introduced the use of multitaper spectral methods in the analysis of pediatric EEG recordings to facilitate comparisons with adult analyses. We provide spectrograms to show how these brain dynamics appear on available EEG monitors.

The design of strategies to track the brain states of children receiving general anesthesia and sedation has not received the attention that this topic has received in adults. Systems neuroscience research that takes account of brain development will be required to accurately define anesthetic states for the entire pediatric age spectrum and to devise principled neurophysiological-based strategies for anesthetic dosing in older infants (\>3 months) and children. Moreover, until the question of whether anesthetics are toxic to the developing brain is answered, design of neurophysiological-based definitions of anesthetic states and design of neurophysiological-based brain monitoring strategies offer the most prudent approaches to mitigating anesthetic risk in this vulnerable population.

Materials and methods {#s4}
=====================

Study design {#s4-1}
------------

The objective of this observational study was to evaluate the effect of postnatal age on electroencephalographic (EEG) activity during sevoflurane general anesthesia in infants 0--6 months old. We recorded multichannel EEGs during administration of sevoflurane general anesthesia for elective surgery, per clinical protocol. End-tidal anesthetic gas volume and video recordings of behavioral activity were time-locked to the EEG recording. The spatial and temporal properties of the infant EEG were evaluated during the awake state, and at two distinct periods during administration of sevoflurane general anesthesia: (1) MOSSA and (2) emergence from sevoflurane general anesthesia ([Figure 1](#fig1){ref-type="fig"}). The age-dependent effects of sevoflurane general anesthesia on the EEG were compared in two groups of infants who were (i) 0--3 months and (ii) 4--6 months of age.

### Participants {#s4-1-1}

Infants who were scheduled for an elective surgical procedure were recruited from the pre-operative clinic at Boston Children\'s Hospital from December 2011 to August 2014. Eligibility criteria consisted of infants between 0 and 6 months postnatal age who required surgery below the neck. All infants were clinically stable on the day of study and American Society of Anesthesiologists\' physical status I or II. Infants were not eligible for inclusion in the study if they were (1) born with congenital malformations or other genetic conditions thought to influence brain development, (2) diagnosed with a neurological or cardiovascular disorder, or (3) born at \<32 weeks post-menstrual age.

Ethical approval was obtained from Boston Children\'s Hospital Institutional Review Board (Protocol Number IRB-P000003544) and classified as a 'no more than Minimal Risk' study. Informed written consent was obtained from parents/legal guardians before each study. The study conformed to the standards set by the Declaration of Helsinki and Good Clinical Practice guidelines.

A total of 36 EEG recordings were performed. Data are presented from 30 infants (0--3 months, n = 11; 4--6 months, n = 19) in the MOSSA analysis. Data are presented from 24 infants (0--3 months, n = 8; 4--6 months, n = 16) for emergence analysis. Details of the study profile and infant demographics are provided in [Figure 2](#fig2){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}, respectively.

### Anesthetic management {#s4-1-2}

Each infant received anesthetic induction with sevoflurane [+]{.ul} nitrous oxide. Nitrous oxide was added at the discretion of the anesthesiologist (29/36 cases). Nitrous oxide was discontinued after placement of an endotracheal tube or laryngeal mask. Propofol was used to facilitate tracheal intubation in 19/36 cases (mean concentration [+]{.ul} standard deviation (SD): 15.8 [+]{.ul} 6.3 mg/kg; range 10--30 mg/kg). No infants were prescribed midazolam or other premedication on the day of surgery. Clinical characteristics for individual infants are given in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}.

MOSSA was comprised of sevoflurane administration with air and oxygen, titrated to clinical signs; end-tidal sevoflurane concentration was adjusted according to the anesthesiologist\'s impression of clinical need, not according to pre-set end-tidal sevoflurane concentration per IRB requirements for the pediatric risk category of 'minimal risk, no potential for benefit'. During MOSSA, the median end-tidal sevoflurane concentration for infants 0--3 months of age was 2.0% (95% CI: 0.8--2.6%, n = 11), and for infants 4--6 months of age was 2.6% (95% CI: 2.4--3.1, n = 19); [Table 1](#tbl1){ref-type="table"}.

Data acquisition {#s4-2}
----------------

All infants were in the supine position throughout the study. Each infant was studied once.

### EEG recording {#s4-2-1}

An EEG cap was used to record EEG activity (WaveGuard EEG cap, Advanced NeuroTechnology, Enschede, Netherlands). 33 recording electrodes were positioned according to the modified international 10/20 electrode placement system at Fz, FPz, FP1, FP2, F3, F4, F7, F8, FC1, FC2, FC5, FC6, Cz, CPz, C3, C4, CP1, CP2, CP5, CP6, Pz, P3, P4, P7, P8, T7, T8, M1, M2, POz, Oz, O1, and O2 ([Figure 1](#fig1){ref-type="fig"}). Reference and ground electrodes were located at Fz and AFz, respectively. The impedance of the electrode-skin interface was kept to a minimum by massaging the skin with an EEG prepping gel (Nu-Prep gel, DO Weaver & Co., CO, USA), and conductive EEG gel was used to optimize contact with the electrodes (Onestep-Clear gel, H+H Medical Devices, Dülmen, Germany).

EEG activity from 0 to 500 Hz was recorded with an Xltek EEG recording system (EMU40EX, Natus Medical Inc., Ontario, Canada). Signals were digitized at a sampling rate of 1024 Hz (or 256 Hz in one case), and a resolution of 16 bit.

### Clinical data collection {#s4-2-2}

Demographics and clinical information, including age, gender, surgical procedure, anesthetic management, were collected from the electronic medical records and from the in-house Anesthesia Information Management System (AIMS). End-tidal sevoflurane, oxygen, and nitrous oxide concentrations were downloaded from the anesthetic monitoring device (Dräger Apollo, Draeger Medical Inc., Telford, PA) to a recording computer in real-time using ixTrend software (ixellence, Wildau, Germany). Signals were recorded at a sampling rate of 1 data point per second. Gross body movement was recorded with a camcorder that was time-locked to the EEG recording (Xltek DSP270x, Natus Medical Inc.).

EEG analysis {#s4-3}
------------

### Data preprocessing {#s4-3-1}

Preprocessing was carried out with Natus NeuroWorks (Natus Medical Inc.) and in-built MATLAB code (MathWorks Inc., Natick, MA). Ear electrodes (M1 and M2) were excluded from the final analysis due to poor surface-to-skin contact for the majority of infants.

EEG signals were re-montaged to a nearest neighbor Laplacian reference using distances along the scalp surface to weight neighboring electrode contributions. We applied an anti-aliasing filter of 80 Hz and down-sampled the EEG data to 256 Hz.

EEG dynamics were analyzed at three distinct periods of (1) MOSSA, (2) awake (pre-anesthesia), and (3) emergence from general anesthesia. (1) *MOSSA analysis*: in the first part of this study, we were interested in characterizing EEG features during MOSSA. For each infant, a 10-min EEG segment during a period of maintenance of general anesthesia adequate for surgery and where end-tidal sevoflurane concentration was maintained at a constant concentration ([+]{.ul}0.1%) was identified. Within this time segment, a 5-min epoch was selected from 'artifact-free' EEG, where motion or electrocautery artifacts were not present in the EEG. Channels with noise or artifacts were excluded from the analysis by visual inspection. EEG data analyzed during MOSSA involved epochs with median time after propofol or nitrous oxide administration of 77 min (IQR 32--93 min). (2) *Awake state to MOSSA analysis*: in the second part of this study, we were interested in characterizing the relationship with EEG features during the awake state, and comparing them to MOSSA. For each infant, the EEG and video recording starting before any anesthetics were administered was identified. Each video was reviewed and the sleep state of the infant identified using behavioral and vocal markers. The awake state was defined as having one of three features (1) eyes open, (2) body movement, and/or (3) crying. For each corresponding EEG segment, we extracted an 11-s 'artifact-free' epoch by visual inspection. If there was no 'artifact-free' data available then we did not include that epoch in the analysis. (3) *Emergence from general anesthesia analysis*: in the third part of this study, we were interested in characterizing relationship with EEG features, end-tidal sevoflurane concentration and onset of body movement. For each infant, an EEG segment starting from 10 min before sevoflurane gas was turned off, and finishing when end-tidal sevoflurane concentration was 0% was identified. For each EEG segment, we extracted a 30-s 'artifact-free' epoch by visual inspection at 10 end-tidal sevoflurane concentration ranges: (1) 0 to \<0.3%; (2) 0.3 to \<0.6%; (3) 0.6 to \<0.9%; (4) 0.9 to \<1.2%; (5) 1.2 to \<1.5%; (6) 1.5 to \<1.8%; (7) 1.8 to \<2.1%; (8) 2.1 to \<2.4%; (9) 2.4 to \<2.7%; and (10) 2.7 to \<3.0%. A 15- or 20-s epoch was used in three occasions. If there was no 'artifact-free' data available in a specific concentration range then we did not include that epoch in the analysis.

### Time-frequency analysis {#s4-3-2}

Spectral analysis of activity was performed with multitaper methods using the Chronux toolbox (<http://chronux.org>) ([@bib4]). Multitaper parameters were set using window lengths of T = 2 s with 1.9 s overlap; time-bandwidth product TW = 2, and number of tapers K = 3. The spectrum of frequencies over time within the 0--30 Hz range was plotted for individual electrodes in each infant.

Infants were divided into two groups according to postnatal age: (1) 0--3 months and (2) 4--6 months. First, group-averaged spectrograms were computed by taking the median power across subjects at each time and frequency at the electrode of interest for each postnatal age cohort (i.e., [Figure 4A,B](#fig4){ref-type="fig"}). Second, group-averaged spectra were computed by taking the mean power of individual spectrograms at each frequency across the entire epoch (5 min for MOSSA, and 30 s for emergence analysis), and then the median (IQR) power at each frequency was calculated for each postnatal age group (i.e., [Figure 4C](#fig4){ref-type="fig"}).

To identify the topographic distribution of specific frequency bands, we first took the mean power spectra of group-averaged spectrograms across the entire epoch (5 min for MOSSA and 30 s for emergence analysis) for each electrode. Then, we averaged the mean power spectra over each EEG frequency band of interest for both postnatal age groups. Scalp EEG frequency band power plots were performed using 3D interpolation of the electrode montage with the topoplot function in EEGLab ([@bib23]).

### Coherence analysis {#s4-3-3}

Coherence analysis was performed using custom-written MATLAB code (MathWorks Inc.; [Source code 1](#SD2-data){ref-type="supplementary-material"}). Coherence quantifies the degree of correlation between two signals at a given frequency. It is equivalent to a correlation coefficient indexed by frequency: a coherence of 1 indicates that two signals are perfectly correlated at that frequency, while a coherence of 0 indicates that the two signals are uncorrelated at the frequency. The coherence between channel i and j is given by$$C_{ij}\left( {f,t} \right) = \left| \frac{S_{ij}\left( {f,t} \right)}{\sqrt{S_{i}\left( {f,t} \right)S_{j}\left( {f,t} \right)}} \right|,$$where *S*~*ij*~ is the cross-spectrum of i, jth electrode and *S*~*i*~ is the spectrum of ith electrode at frequency *f* and time *t*. The spectrum is calculated by using multitaper methods with TW = 3, K = 5, T = 2 s, and a non-overlapping window. A coherogram graphically illustrates coherence for a range of frequencies plotted across time.

For *frontal coherence analysis*, we calculated and plotted coherence between electrodes F7 and F8, based on analyses using these electrodes in adult studies ([@bib3]). To compute the group-averaged frontal coherogram, we took the median coherence across infants at each time point and frequency. For *global coherence analysis*, we divided each segment into non-overlapping 2-s windows and computed the cross-spectral matrix. To remove noise artifact, the median over 10 windows of the real and imaginary parts of each entry in the cross-spectral matric was taken. Then, we performed an eigenvalue decomposition analysis of the cross-spectral matrix at each frequency. The cross-spectral matrix at each frequency can be factorized as$$S\left( f \right) = U\left( f \right)\text{Λ}\left( f \right)U\left( f \right)^{H},$$where *U*^H^ is the complex conjugate transpose of *U* and a unitary matrix whose *i*th column is the eigenvector *u*~*i*~ of *S*, and Λ is the diagonal matrix whose diagonal elements are the corresponding eigenvalues, Λ~*ii*~ = λ~*i*~. The global coherence is the ratio of the largest eigenvalue to the sum of eigenvalues ([@bib18]):$$C_{global}\left( f \right) = \frac{\lambda_{\max}\left( f \right)}{\sum_{i = 1}^{N}\lambda_{i}\left( f \right)}.$$

When the largest eigenvalue is large compared with the remaining ones, the global coherence is close to 1. We computed the global coherence at each frequency using 5-min epochs for MOSSA. To get group-averaged global coherence plot, we took a median across infants. We refer to the eigenvector *u*~*max*~ corresponding to the largest eigenvalue *λ*~max~ at a given frequency as the principal mode of oscillation for that frequency and the coherence of electrode sites was obtained by the absolute value square of the eigenvector ([@bib47]). This means that the eigenvector describes a coherent spatial distribution. Spatial coherence at each frequency band was computed by taking an average across the frequency range at each electrode. Group-averaged scalp coherence distribution was computed by taking the median across infants and displayed using the topoplot function in EEGLab.

Behavioral analysis {#s4-4}
-------------------

Behavioral data during (1) the awake state and (2) emergence from general anesthesia were analyzed post hoc. (1) *For awake analysis*: videos were reviewed frame-by-frame prior to anesthesia to identify the sleep state of each infant. The sleep state of the infant was determined using behavioral and vocal markers. The awake state was defined as from one of three features (a) eyes open, (b) body movement, and/or (c) crying. (2) *For emergence analysis*: videos were reviewed frame-by-frame to identify the time point (in seconds) where gross body movement first occurred. The corresponding end-tidal sevoflurane concentration was extracted from the ixTrend data recording. The percentage of infants who displayed gross body movement in each end-tidal sevoflurane concentration range was evaluated for each group.

Statistical analysis {#s4-5}
--------------------

Data are shown as median (95% CI of median) unless otherwise stated. Statistical analysis performed using SPSS Statistics v.21 (IBM, Armonk, NY) and custom-written MATLAB code (MathWorks Inc.; [Source code 2](#SD3-data){ref-type="supplementary-material"}).

To assess statistical significance for the difference in power at each frequency, we computed the 95% CI by using a frequency domain-based bootstrapping algorithm ([@bib34]). We drew Fourier coefficients from normal Gaussian distribution with variance of its spectral power for each subject. From the Fourier coefficients, we computed replicates of spectral power for each subject and took the median value (i.e., power, or coherence, where relevant) across infants within each postnatal age group and computed group differences (using paired comparisons, where relevant), following this a new set was randomly selected in each postnatal age group and the analysis repeated. We repeated this 2000 times and calculated the 95% CI using the median difference at each frequency.

### Emergence analysis {#s4-5-1}

To evaluate the power difference at each frequency between MOSSA and after the first movement, we first identified 'artifact-free' epochs for analysis. For MOSSA data, we extracted a 10- to 20-s 'artifact-free' epochs by visual inspection around 10 min before gas-off. For movement data, we selected a 5- to 30-s 'artifact-free' epoch within 2 min after the onset of body movement. We computed the 95% CI using the bootstrap analysis of the difference between the median power spectra across infants in MOSSA data and movement data in each age group.

Code {#s4-6}
----

Custom-written MATLAB code (with simulated data) for computing global coherence ([Source code 1](#SD2-data){ref-type="supplementary-material"}), and multitaper spectra and bootstrap CIs ([Source code 2](#SD3-data){ref-type="supplementary-material"}) is given in the Supplemental Materials.
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Characteristics of individual infants. Subjects listed according to postnatal age. Data given for all infants included in the MOSSA analysis. M, months; MOSSA, Maintenance Of a Surgical State of Anesthesia; PNA, Postnatal Age; Wgt., weight. A--All infants were administered glycopyrrolate-neostigmine to reverse the neuromuscular blockade towards the end of surgery (except infants 1, 3, and 15). B--Infant was additionally administered clonidine for hypertension.
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Custom-written MATLAB code (with simulated data) for computing global coherence.
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Custom-written MATLAB code (with simulated data) for computing multitaper spectra and bootstrap CIs.
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Thank you for sending your work entitled "Age-dependent electroencephalogram (EEG) patterns during sevoflurane general anesthesia in infants" for consideration at *eLife*. Your article has been favorably evaluated by Eve Marder (Senior editor) and three reviewers, one of whom, Jody Culham, is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

Main revisions needed:

All three reviewers found the study interesting and important; however, there are several issues that must be addressed in a revision. The key changes required are summarized in the numbered points below. In addition specific comments from Reviewer \#2 are also appended to provide additional detail.

1\) One expert reviewer brought up a number of important concerns about the brain states of infants during different stages. Specifically, the revision should address the validity of using movement as a proxy for emergence, the possibility of sleep during emergence, and the lack of data from the pre-anesthesia states. See Reviewer \#2\'s detailed points below.

2\) The possibility that anesthetic variances could explain the data should be explicitly discussed. This includes explicit statistics to determine whether the weights and durations of anesthesia in the two age groups differed significantly. See Reviewer \#2\'s detailed points below.

3\) More statistical comparisons of the putative differences are needed. See Reviewer \#2\'s detailed points below.

4\) One reviewer suggests one area that can be addressed in the Discussion is the role, if any, of the developmental change in the grey/white matter ratios that have been documented in infant MRI studies. This may provide a clinically measurable structural basis for the neurophysiological changes observed with sevoflurane anesthesia in this report.

5\) The authors should reconsider the framing of the conclusions of the paper, although there were some conflicting views about this.

One main suggestion, which came up during the initial manuscript consultation amongst *eLife* editors was the need to make it clearer what the relevance/implications of the results are not just for clinical practice but for understanding brain development. *eLife* is a biological sciences journal so we are looking for papers that advance our understanding of the underlying biology. There is some interesting discussion about possible reasons for the differential effects of anesthesia in younger infants, older infants and adults. However, this is somewhat underplayed in the manuscript as it stands. For example, the Abstract says, "these differences in EEG dynamics are likely due to brain development", but doesn\'t unpack why these are interesting.

That said, given some of the concerns raised by reviewers, we do not want to push you to draw stronger conclusions than the data warrant, particularly if some of the differences may relate to potential confounds such as anesthesia levels. One reviewer also wonders if the conclusions in the final sentence of the Abstract are too strong. See Reviewer \#2\'s detailed points below (regarding the Abstract).

*Detailed comments from Reviewer \#2*:

This is a really interesting study that is challenging to perform and timely in terms of the results generated and their relevance. I am generally enthusiastic about this paper, but more work is required to be convinced by the authors\' main interpretation and explanation of their results. Namely, that the developing brain is the most likely explanation for their convincing and well analysed EEG results showing clear differences during surgical anaesthesia between 0-3 and 4-6 month old babies. I describe below in more detail this issue alongside minor other concerns.

1\) Discussion, first paragraph. Please expand on the discussion of the flaws in using only this behavioural measure (see more below). Is it possible to relate any other measure (respiration/heart rate change) to these crude movement behavioural measures so that we can be more sure that the movement as measured relates to something that additional suggests true emergence/awake-like state (see below for more on this and complexity of sleep stages).

2\) In the second paragraph of the subsection headed "Studies of EEG dynamics of infant brain under general anesthesia". Is this finding better explained by \<3 month-old babies being more likely to enter a sleep stage during emergence? The authors admit this is possible later in the manuscript. This confound needs more discussion and to be offered as a viable additional explanation perhaps.

3\) In the subsection headed "Studies of EEG dynamics in adults under general anesthesia". The lack of pre-anaesthetised baseline data is key. While understandably a complex environment, presumably the electrodes were already in place and so I am unclear why these data were not taken prior to induction of anaesthesia? How can you relate movement to 'awake' EEG if you don\'t know what genuine awake EEG looks like in these different age groups? These data are needed surely to make sense of anaesthetised states---possibly it\'s the relative EEG changes from fully awake to anaesthetised in each baby that are as relevant as the between ages changes during 'assumed anaesthetic dose/state'?

4\) In the subsection headed "Anesthetic Management". Where the methods are described we begin to unravel some of the major confounds here. These need to be brought earlier into the Introduction and Results and explanation of findings. They are buried here. Please include the anaesthetic data in [Table 1](#tbl1){ref-type="table"} and provide statistics. Clearly there are many differences here---understandable, as routine clinical care was performed and this is an opportunistic uncontrolled study, but as such the authors must alert the readership to the likelihood that anaesthetic variances might largely explain their data. As written, this information is not highlighted or discussed and the reader is very strongly led to believe this is all due to the very interesting developmental changes. I don\'t doubt that there is a profound developmental influence, but we need to be convinced these other factors are not relevant. Firstly, propofol was used for some babies but not others. We do not know whether this was evenly distributed between the two age groups or not. Please detail. There are differences in duration and amount of anaesthetic used between age groups, but again we\'re not told whether this was significantly different for the two age groups. These factors alone will confound the EEG signals; therefore, please confirm whether they are significantly different or not---hopefully not and then we can be more convinced by their developmental explanation.

5\) [Figure 5](#fig5){ref-type="fig"}. While frontal-occipital power is not different there does appear to be more power in the slow waves in the temporal regions; is this significant?

6\) [Figure 7](#fig7){ref-type="fig"}. Again, temporal lobes 'look' different but we\'re not given any statistical comparisons. I wonder whether the likely developing insula cortex within the temporal lobes might be relevant here?

7\) [Figure 10](#fig10){ref-type="fig"}. Can we segregate body movements into those with eyes open/closed or whether concomitant with being obviously awake, etc? No information is given about this crude measure, its variance and therefore whether there were systematic differences in the age groups. For example, can we eliminate the question regarding whether babies were still predominately asleep in 0-3 month group even with body movements compared to the 4-6 month olds? Also, what does the body movement do to the quality of EEG recordings and were any body movements of the head? More detail is needed considering this was the single behavioural anchor used to determine emergence and to time-lock the EEG analysis to.

8\) [Table 1](#tbl1){ref-type="table"}. We need statistics here. There is a large weight difference and differences in length of anaesthesia, which means the brains of younger babies were loaded with more anaesthetic and this will impact emergence. Was this a significant difference? More details needed about the reasons for surgery---any brain/spinal cord related? Please also include from Methods into this table the dose/duration details regarding all anaesthetic agents used with statistics.

9\) Abstract: I don\'t think you can make such a strong conclusion at this stage and based upon your conclusion. You might live to regret stating such a limiting statement regarding the current likelihood that EEG indices could be used. Arguably they might provide excellent measures once you know (and can factor in) the neurophysiological state of brain from which they derive. Please alter the final sentence.

10.7554/eLife.06513.022

Author response

*1) One expert reviewer brought up a number of important concerns about the brain states of infants during different stages. Specifically, the revision should address the validity of using movement as a proxy for emergence, the possibility of sleep during emergence, and the lack of data from the pre-anesthesia states. See Reviewer \#2\'s detailed points below*.

Please see our response to Reviewer \#2 (Comment \# 1, 2, 3 and 7).

*2) The possibility that anesthetic variances could explain the data should be explicitly discussed. This includes explicit statistics to determine whether the weights and durations of anesthesia in the two age groups differed significantly. See Reviewer \#2\'s detailed points below*.

Please see our response to Reviewer \#2 (Comment \# 4 and 8).

*3) More statistical comparisons of the putative differences are needed. See Reviewer \#2\'s detailed points below*.

Please see our response to Reviewer \#2 (Comment \# 5 and 6).

*4) One reviewer suggests one area that can be addressed in the Discussion is the role, if any, of the developmental change in the grey/white matter ratios that have been documented in infant MRI studies. This may provide a clinically measurable structural basis for the neurophysiological changes observed with sevoflurane anesthesia in this report*.

Structural MRI images from infants under 6 months show relatively high water content of both grey and white matter at this age. Postmortem studies show that significant myelination occurs postnatally and proceeds in a posterior-to-anterior fashion. Myelination begins in the pons and cerebellar peduncles, and by 3 months has extended to the optic radiation and splenium of the corpus callosum. At around 8-12 months of age, the white matter associated with the frontal parietal and occipital lobes becomes apparent. The emergence of frontal alpha activity at around 3 to 4 months postnatal ages likely parallels the regional changes in cortico-cortical and thalamocortical maturation. Please see the subsection "Brain development as a source of changes in EEG dynamics with age" in the Discussion.

*5) The authors should reconsider the framing of the conclusions of the paper, although there were some conflicting views about this*.

*One main suggestion, which came up during the initial manuscript consultation amongst* eLife *editors was the need to make it clearer what the relevance/implications of the results are not just for clinical practice but for understanding brain development.* eLife *is a biological sciences journal so we are looking for papers that advance our understanding of the underlying biology. There is some interesting discussion about possible reasons for the differential effects of anesthesia in younger infants, older infants and adults. However, this is somewhat underplayed in the manuscript as it stands. For example, the Abstract says, "these differences in EEG dynamics are likely due to brain development", but doesn\'t unpack why these are interesting*.

Please see our response to Reviewer \#2 (Comment \# 9).

*That said, given some of the concerns raised by reviewers, we do not want to push you to draw stronger conclusions than the data warrant, particularly if some of the differences may relate to potential confounds such as anesthesia levels. One reviewer also wonders if the conclusions in the final sentence of the Abstract are too strong. See Reviewer \#2\'s detailed points below (regarding the Abstract)*.

Detailed comments from Reviewer \#2:

*This is a really interesting study that is challenging to perform and timely in terms of the results generated and their relevance. I am generally enthusiastic about this paper, but more work is required to be convinced by the authors\' main interpretation and explanation of their results. Namely, that the developing brain is the most likely explanation for their convincing and well analysed EEG results showing clear differences during surgical anaesthesia between 0-3 and 4-6 month old babies. I describe below in more detail this issue alongside minor other concerns*.

*1) Discussion, first paragraph. Please expand on the discussion of the flaws in using only this behavioural measure (see more below). Is it possible to relate any other measure (respiration/heart rate change) to these crude movement behavioural measures so that we can be more sure that the movement as measured relates to something that additional suggests true emergence/awake-like state (see below for more on this and complexity of sleep stages)*.

We agree with the reviewer that there are uncertainties and limitations with a variety of behavioral and physiologic measures of recovery from the anesthetic state. In studies of adult volunteers, response to verbal command is often used; this is not feasible for infants. The advantage of using gross movement as a measure of emergence is that it is well-defined in infants and children (e.g. Bould et al., 2011 Pediatric Anesthesia; McCann et al., 2002; Pediatric Anesthesia; Davidson et al., 2001 Anesthesia & Analgesia). Onset of movement relates to the anesthetic state, namely the ability of general anesthetics to suppress movement. Respiration, heart rate and blood pressure also reflect effects of anesthesia but in a more complex and derivative manner. Each of these parameters can be influenced by anesthetic state, but also can be influenced by a number of factors summarized in [Author response table 1](#tbl2){ref-type="table"} below. As per our IRB protocol, to make this a minimal risk study of infants, we had to leave all aspects of drug administration to the anesthesiologist's discretion.10.7554/eLife.06513.023Author response table 1.Factors that challenge use of non-behavioral measures during emergence**DOI:** [http://dx.doi.org/10.7554/eLife.06513.023](10.7554/eLife.06513.023)**Influencing factorsReasonRelation to our study**Amount of painful stimulation from surgery affecting respiration & heart rate changeVariability in degree of suppression from nociceptive afferent drive by:• Local or regional anesthesia (e.g. field blocks for hernia repairs, or penile blocks for hypospadias repair)• Opioid dosing (dose and time course)[Supplementary File 1](#SD1-data){ref-type="supplementary-material"} provides details on the individual infant clinical data.Control of respiratory function• Variability in tidal volume and rate delivered via mechanical ventilation during anesthesia according to individual anesthesiologist's clinical decisions. Resulting pCO2 influences ventilatory drive during emergence.• Variability in anesthesiologist's method to convert from controlled to assisted or spontaneous ventilationInformation unavailable.Pharmacologic effects on heart rateVariability in use of neuromuscular blockade and need for reversal of neuromuscular blockade (case-dependent):• Reversal of NM blockade requires cholinesterase inhibitors (e.g. neostigmine), which produce bradycardia, and muscarinic antagonists (i.e. atropine or glycopyrrolate), which produce tachycardia. Heart rate during emergence can reflect individual differences in responses to these, along with other contributors to sympathetic and parasympathetic heart rate modulation.• Variability in timing of NM block reversal drug administration at the end of surgery, and effects on heart rate[Supplementary File 1](#SD1-data){ref-type="supplementary-material"} provides details on the individual infant clinical data.

We collected respiration rate, heart rate and non-invasive blood pressure data during emergence. Mean respiration rate and heart rate over a 20-minute period of emergence are shown for all infants in [Author response image 1](#fig13){ref-type="fig"}. The onset of body movement is marked as time 0.10.7554/eLife.06513.024Author response image 1.Onset of body movement is not associated with changes in respiration rate.(A) Mean respiration rate (breaths per min) and (B) heart rate were calculated for all infants over a 20 minute period: 10-min prior to first visible body movement, and 10min after. Time 0 (grey dashed line) indicates where first body movement was observed. Data represented as mean (+/- SD).**DOI:** [http://dx.doi.org/10.7554/eLife.06513.024](10.7554/eLife.06513.024)

Respiration rate data was sampled at every 1 min using a clinical movement transducer. The low temporal resolution meant that subtle changes in respiration rate at the time of first body movement were not detectable adequate second-by-second accuracy ([Author response image 1A](#fig13){ref-type="fig"}). Based on the available data, we show there were no changes in respiration rate at 1 min before body movement compared to 1 minute after body movement (p=0.56, paired Student's t-test; [Author response table 2](#tbl3){ref-type="table"}).10.7554/eLife.06513.025Author response table 2.Change in respiration rate and heart rate at the time of first body movement**DOI:** [http://dx.doi.org/10.7554/eLife.06513.025](10.7554/eLife.06513.025)Baseline(1min prior to first body movement)Post-movement(1min after first body movement)**p-value**^A^**Respiration rate (breaths per min)**All infants0-3M4-6M29.4 (13.4)36.3 (14.7)23.5 (11.5)30.8 (12.1)39.1 (13.3)25.7 (8.1)0.590.440.90**Heart rate (bpm)**All infants0-3M4-6M145 (23)156.4 (21.7)139.6 (22.1)150 (25.3)165 (22)143.9 (24.4)**0.0018 (\*\*)0.042 (\*)0.023 (\*)**

Data in parenthesis represent standard deviation. Bpm, beats per min; M, months old; min, minute. A -- Paired Student's t-test.

Asterisks indicate level of significance where: \*, p\<0.05; and \*\*, p\<0.01.

Onset of body movement was associated with increased heart rate in all infants. We show that mean HR over 1 min period immediately prior to first visible body movement was 145 bpm (SD: 23) and significantly increased during first body movement \[Mean HR: 150 bpm (SD: 25.3); p=0.0018, paired Student's t-test; [Author response table 2](#tbl3){ref-type="table"}\]. Non-invasive blood pressure was taken every 5mins using an automated pressure cuff. The low sampling rate meant that blood pressure measurements were taken before and after first body movement within time fame of +/- 5 mins. Therefore, not all subjects had a blood pressure sample taken at both 1 min prior to- and at 1 min after first visible body movement; this parameter could not be included in the analysis.

We have edited the Discussion section "Study Limitations and Constraints" to include the following: "In place of formal behavioral assessments of consciousness, which would not be feasible in children \[...\] also reflect effects of anesthesia but in a more complex manner being dependent on drug administration and clinical state of the patient. "

*2) In the second paragraph of the subsection headed "Studies of EEG dynamics of infant brain under general anesthesia". Is this finding better explained by \<3 month-old babies being more likely to enter a sleep stage during emergence? The authors admit this is possible later in the manuscript. This confound needs more discussion and to be offered as a viable additional explanation perhaps*.

We used onset of behavioral movement as a surrogate marker for onset of emergence, and this has been used with other behavioral measures such as crying (or attempting to cry), gagging on an endotracheal tube, eye opening and looking around to describe awakening in neonates and infants (Bould et al., 2011 Pediatric Anesthesia). All infants included in the emergence analysis required extubation. The standard anesthetic practice to extubate uses one of two ways: (1) "Awake with movement", meaning with body movement, coughing, and return of some reflex activity, or (2) "Deep", meaning with spontaneous breathing, but in a deeper plane of anesthesia, specifically without coughing. For \>90% of infant anesthetics at Boston Children's Hospital, awake extubation is preferred, although anesthesiologists differ in the degree of responsiveness required prior to extubation. It is plausible that some infants may remain sedated or unconscious despite recovering movement immediately following surgery. Nevertheless, our comparisons of the EEG properties between arousal states indicate striking similarities between the awake state and emergence in infants 0 to 3 months (as well as between the awake state and MOSSA). The implications of these findings demonstrate the challenges faced when using surface EEG measures to evaluate anesthetic depth in very young infants.

*3) In the subsection headed "Studies of EEG dynamics in adults under general anesthesia". The lack of pre-anaesthetised baseline data is key. While understandably a complex environment, presumably the electrodes were already in place and so I am unclear why these data were not taken prior to induction of anaesthesia? How can you relate movement to 'awake' EEG if you don\'t know what genuine awake EEG looks like in these different age groups? These data are needed surely to make sense of anaesthetised states---possibly it\'s the relative EEG changes from fully awake to anaesthetised in each baby that are as relevant as the between ages changes during 'assumed anaesthetic dose/state'*?

Collecting "awake pre-anesthesia" EEG data from infants is technically and logistically very challenging. Ideal recording conditions require the infant to be relaxed i.e. well fed, lying still, and in a cot. These conditions help avoid EEG signal contamination from muscle and movement, and external electrical noise. Most infants in the preoperative holding area were hungry (having abstained from feeding at least 4-6 hours prior to surgery per anesthesiologist requirement for an "empty stomach" to reduce the risk of tracheal aspiration of gastric contents). They were easily agitated and consequently episodically physically active during the Awake EEG recordings. Those infants who required comforting were often held in a parent's arms; this also generated external electrical noise.

Following the reviewer's suggestion, we now provide awake- state data analysis in the revised report. For the reasons listed above, we made extensive effort to identify good artifact-free preoperative epochs, and used 11-second samples of artifact-free EEG data for the awake-state analysis. Awake-state data were evaluated in each group to identify age-dependent differences, and compared to 11-second samples of MOSSA data to identify sevoflurane general anesthesia dependent differences.

Our findings show that slow and delta activity are the prominent frequencies during the awake state at all ages. There were no discernable changes in power between the awake state and MOSSA in infants aged 0 to 3 months. However, increased theta (\>6Hz) and alpha were shown during the MOSSA state compared to the awake-state in infants 4 to 6 months of age. These findings suggest that the emergence of alpha activity is age-dependent, and a marker of anesthetic induced unconsciousness in infants 4 to 6 months.

The Methods section is now edited to reflect the inclusion of awake- state data. The results include an additional section detailing the awake-state data analysis with comparisons to the "MOSSA" data ([Figure 10](#fig10){ref-type="fig"} and [Figure 10--figure supplement 1](#fig10s1){ref-type="fig"}).

*4) In the subsection headed "Anesthetic Management". Where the methods are described we begin to unravel some of the major confounds here. These need to be brought earlier into the Introduction and Results and explanation of findings. They are buried here. Please include the anaesthetic data in* [*Table 1*](#tbl1){ref-type="table"} *and provide statistics. Clearly there are many differences here---understandable, as routine clinical care was performed and this is an opportunistic uncontrolled study, but as such the authors must alert the readership to the likelihood that anaesthetic variances might largely explain their data. As written, this information is not highlighted or discussed and the reader is very strongly led to believe this is all due to the very interesting developmental changes. I don\'t doubt that there is a profound developmental influence, but we need to be convinced these other factors are not relevant. Firstly, propofol was used for some babies but not others. We do not know whether this was evenly distributed between the two age groups or not. Please detail. There are differences in duration and amount of anaesthetic used between age groups, but again we\'re not told whether this was significantly different for the two age groups. These factors alone will confound the EEG signals; therefore, please confirm whether they are significantly different or not---hopefully not and then we can be more convinced by their developmental explanation*.

We have edited [Table 1](#tbl1){ref-type="table"} to include the requested information. This includes: (1) detail from the methods i.e. end-tidal sevoflurane concentration during MOSSA epochs; (2) general anesthetic management i.e. number of subjects given propofol, duration of anesthetic exposure; and (3) statistical comparisons. [Table 1](#tbl1){ref-type="table"} also cross-references to a supplementary table detailing individual infants' demographics, clinical characteristics and anesthetic management.

The findings related to this study are possibly confounded by differences in anesthetic depth among individuals during MOSSA. For example, the addition of propofol to the anesthetic or increase in end-tidal sevoflurane concentration can potentially alter the depth of anesthesia as well as the characteristics of the EEG spectra.

End-tidal sevoflurane concentration requirements during MOSSA were significantly lower in the 0-3 month infants compared to the 4-6 month infants (p=0.002, Mann-Whitney U-test; [Table 1](#tbl1){ref-type="table"}). We performed a secondary analysis to control for potential dose effects by comparing EEG spectra during MOSSA at identical end- tidal sevoflurane concentrations of 1.8% across infants. At this lighter concentration (compared to MOSSA), the patterns of EEG activity observed were also seen during MOSSA suggesting the observed differences between the two groups were not likely due to a dose effect. We have edited the Results section (see EEG features during MOSSA) as follows:

"End-tidal sevoflurane requirements during MOSSA were significantly lower in infants 0 to 3 months compared to infants 4 to 6 months of age ([Table 1](#tbl1){ref-type="table"}). Therefore, we performed a secondary analysis to control for potential dose effects by comparing EEG spectra during MOSSA at identical end-tidal sevoflurane concentrations of 1.8% across infants. We chose 1.8% end-tidal sevoflurane because all of the infants received this concentration for at least 30s during surgery, and did not exhibit body movement or reflex activity at this plane of anesthesia suggesting a behavioral state comparable to MOSSA. At 1.8% end-tidal sevoflurane, frontal group-median spectrograms at F7 show slow and delta power was dominant over other frequencies in both age groups ([Figure 4--figure supplement 1A and B](#fig4s1){ref-type="fig"}). Higher frequency oscillations in the theta and alpha range were more prominent in infants 4 to 6 months of age ([Figure 4-- figure supplement 1C-G](#fig4s1){ref-type="fig"}). The patterns of EEG activity observed during MOSSA were also seen during lighter planes of MOSSA at 1.8% end-tidal sevoflurane suggesting that the observed differences between the two groups are not likely due to a dose effect."

We found no significant differences in the distribution of propofol administration between age groups (0-3M, 27.3%, 4- 6M, 42.1%; Fisher's exact test, p=0.08; [Table 1](#tbl1){ref-type="table"}). There were no differences in the duration of anesthetic exposure between age groups (p=0.18, Mann-Whitney U test). Collectively, these findings indicate that although a lower dose of anesthetic was required to maintain a surgical state of anesthesia in the younger infants, the differences seen between the groups are less likely to reflect deeper levels of anesthesia and more likely to be age-dependent.

*5)* [*Figure 5*](#fig5){ref-type="fig"}*. While frontal-occipital power is not different there does appear to be more power in the slow waves in the temporal regions; is this significant*?

We evaluated spectral power at the temporal regions and along the midline areas. Power in the slow frequencies was significantly greater in the left (T7) temporal region when compared to key midline electrodes located in the frontal (FPz), central (Cz) and occipital (Oz) regions in all infants ([Author response image 2](#fig14){ref-type="fig"}). These findings that midline activity is compromised of significantly lower power compared to temporal regions are likely due to heterogeneity of skull thickness or bone conductance, and physical changes in the brain.10.7554/eLife.06513.026Author response image 2Midline EEG spectral power is lower compared to temporal regions during MOSSA in all infants.Temporal (T7) electrode comparisons are shown for (A-E) vs. frontal midline (FPz); (F-J ), vertex (Cz); (K-P), occipital midline (Oz); and (Q- U) lateral temporal area (T8). For each electrode pair, a schematic of electrode locations ( A, F, K, Q) are shown with the respective analysis of power spectra in infants aged 0-3 months ( B, G, L, R), and 4-6 months (C, H, M, S), and 95% CI, paired bootstrap analysis for infants 0-3 months (**D, I, O, T**), and 4-6 months of age (**E, J, P, U**).**DOI:** [http://dx.doi.org/10.7554/eLife.06513.026](10.7554/eLife.06513.026)

In neonates and infants, the skull is thinner and more vascularized than in adults. The cranial bones are un-fused at birth, separated by fontanels and sutures for several postnatal months to accommodate the rapid growth of the brain. The fontanels are located at the midline junctions of bregma and lamda, and have a thinner zone in the skull; where the skull is thinner, it is more conductive. It is plausible that a high signal to noise ratio is obtained over these regions and contributes to these spatial differences in power.

*6)* [*Figure 7*](#fig7){ref-type="fig"}*. Again, temporal lobes 'look' different but we\'re not given any statistical comparisons. I wonder whether the likely developing insula cortex within the temporal lobes might be relevant here*?

Please see our response to Point 5 above. We speculate that the predominance of lower frequency activity seen reflects less cortico-cortical generator activity, and more thalamocortical generator activity (Michelle de Haan, Infant EEG and Event-Related Potentials, Psychology Press, 2013). Future studies using complementary techniques are needed for accurate source localization (i.e. with high density EEG electrode arrays) and evaluation of the origin of deeper cortical and subcortical signals (i.e. fMRI, PET).

*7)* [*Figure 10*](#fig10){ref-type="fig"}*. Can we segregate body movements into those with eyes open/closed or whether concomitant with being obviously awake, etc? No information is given about this crude measure, its variance and therefore whether there were systematic differences in the age groups. For example, can we eliminate the question regarding whether babies were still predominately asleep in 0-3 month group even with body movements compared to the 4-6 month olds? Also, what does the body movement do to the quality of EEG recordings and were any body movements of the head? More detail is needed considering this was the single behavioural anchor used to determine emergence and to time-lock the EEG analysis to*.

Please see our response to Point 2 above. The EEG power spectra in infants 0-3 months during MOSSA is comparable to that of emergence, as well as the awake state. The findings of our study demonstrate how at present, features of the EEG make it challenging to monitor anesthetic depth in infants aged 0-3 months of age, compared to older infants.

The reviewer is rightly concerned about the influence of body movement on the quality of EEG recordings. We made extensive effort to identify good artifact-free emergence epochs, and used 10-30-second samples of artifact-free EEG data for the Emergence analysis.

We anticipate performing future studies examining the time course of events during emergence using detailed analysis of cortical activity with behavioral (evoked and purposeful), and physiologic measures.

*8)* [*Table 1*](#tbl1){ref-type="table"}*. We need statistics here. There is a large weight difference and differences in length of anaesthesia, which means the brains of younger babies were loaded with more anaesthetic and this will impact emergence. Was this a significant difference? More details needed about the reasons for surgery---any brain/spinal cord related? Please also include from Methods into this table the dose/duration details regarding all anaesthetic agents used with statistics*.

The patterns of uptake of inhalation anesthetics depend on time course of inhaled concentrations, alveolar ventilation, cardiac output and blood to gas and gas to oil partitioning. In steady-state, for an insoluble anesthetic such as sevoflurane, brain partial pressure is close to inspired partial pressure, with little dependence on body weight or brain weight. The anesthetic concentration was titrated by the anesthesiologist based on clinical considerations that we did not control. Nevertheless, the difference in mean end -tidal sevoflurane concentration between infants 0 to 3 months, and 4 to 6 months was small ([Table 1](#tbl1){ref-type="table"}). Previous studies of MAC for sevoflurane in infants showed a very slight age-dependence, with newborns and very young infants tending towards slightly lower MAC values compared to infants around 4 to 6 months of age. We have provided statistical information on the demographics and duration of anesthesia in [Table 1](#tbl1){ref-type="table"} of the revised article. We show there were no differences in the duration of anesthetic exposure between the age groups (p=0.18, Mann-Whitney U test).

*9) Abstract: I don\'t think you can make such a strong conclusion at this stage and based upon your conclusion. You might live to regret stating such a limiting statement regarding the current likelihood that EEG indices could be used. Arguably they might provide excellent measures once you know (and can factor in) the neurophysiological state of brain from which they derive. Please alter the final sentence*.

The last sentence of the Abstract now reads: "We demonstrate the need to apply age-adjusted analytic approaches in order to develop neurophysiologic-based strategies for pediatric anesthetic state monitoring."

[^1]: These authors contributed equally to this work.

[^2]: These authors are second equal contributors.

[^3]: Data given as median with 95% Confidence Interval (CI) Limit, unless otherwise stated. All infants included in MOSSA analysis. Six infants were excluded from the emergence analysis due to anesthetic management or technical reasons ([Figure 2](#fig2){ref-type="fig"}); 3 infants aged 0--3 months and 3 infants aged 4--6 months. 95% CI limit of median.

[^4]: MOSSA, Maintenance Of a Surgical State of Anesthesia.

[^5]: Mann--Whitney U-test.

[^6]: Fisher\'s exact test.

[^7]: p \< 0.05 considered statistically significant. [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} provides characteristics for individual infants included in the analysis.
